Hospital Universitario Germans Trias i Pujol - Institut Catala d'Oncologia

Barcelona 08916

0 studies enrolling now · 1 studies all time

What they study most

Inflammatory Breast Cancer Stage IV, Triple Negative Breast Cancer

Studies at this site

• Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With TNBC — Stopped early